Skip to main content

Advertisement

SpringerLink
Log in

Baicalein attenuates renal fibrosis by inhibiting inflammation via down-regulating NF-κB and MAPK signal pathways

  • Original Paper
  • Published:
Journal of Molecular Histology Aims and scope Submit manuscript

Abstract

Baicalein is a natural flavonoid that possesses notable anti-inflammatory effects. In this study, we detected whether baicalein protects against inflammatory response in unilateral ureteral obstruction mice model to ameliorate tubulointerstitial fibrosis. Baicalein treatment significantly attenuated tubulointerstitial fibrosis by markedly reducing fibronectin and collagen-I. The downregulation of alpha-smooth muscle actin and upregulation of E-cadherin indicated that the epithelial–mesenchymal transition process was suppressed. Furthermore, baicalein administration blocked the infiltration of macrophages and lymphocytes, as evidenced by the significantly reduced CD68 and CD3 positive cells. Meanwhile, the mRNA expression of the pro-inflammatory cytokines tumor necrosis factor-α, interleukin-1β, and monocyte chemotactic protein in baicalein-treated groups was markedly reduced compared with the vehicle-treated group. More importantly, unilateral ureteral obstruction induced the activation of NF-κB and mitogen-activated protein kinase signal pathways to switch on inflammatory response to aggravate kidney fibrosis, but these effects were mitigated by baicalein. These data demonstrate that baicalein could inhibit inflammatory process via inactivation of NF-κB and MAPK signal pathways to execute its anti-fibrotic actions in obstructive kidney disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Bani-Hani AH et al (2009) IL-18 neutralization ameliorates obstruction-induced epithelial–mesenchymal transition and renal fibrosis. Kidney Int 76:500–511. doi:10.1038/ki.2009.216

    Article  CAS  PubMed  Google Scholar 

  • Boutet A, De Frutos CA, Maxwell PH, Mayol MJ, Romero J, Nieto MA (2006) Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney. EMBO J 25:5603–5613. doi:10.1038/sj.emboj.7601421

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Crisman JM, Richards LL, Valach DP, Franzoni DF, Diamond JR (2001) Chemokine expression in the obstructed kidney. Exp Nephrol 9:241–248

    Article  CAS  PubMed  Google Scholar 

  • de Borst MH et al (2009) c-Jun NH2-terminal kinase is crucially involved in renal tubulo-interstitial inflammation. J Pharmacol Exp Ther 331:896–905. doi:10.1124/jpet.109.154179

    Article  PubMed  Google Scholar 

  • Eddy AA (2014) Overview of the cellular and molecular basis of kidney fibrosis. Kidney Int Suppl 4:2–8. doi:10.1038/kisup.2014.2

    Article  CAS  Google Scholar 

  • Eddy AA, Lopez-Guisa JM, Okamura DM, Yamaguchi I (2012) Investigating mechanisms of chronic kidney disease in mouse models. Pediatr Nephrol 27:1233–1247. doi:10.1007/s00467-011-1938-2

    Article  PubMed Central  PubMed  Google Scholar 

  • Esteban V et al (2004) Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. JASN 15:1514–1529

    Article  CAS  PubMed  Google Scholar 

  • Fan JM, Huang XR, Ng YY, Nikolic-Paterson DJ, Mu W, Atkins RC, Lan HY (2001) Interleukin-1 induces tubular epithelial-myofibroblast trans differentiation through a transforming growth factor-beta1-dependent mechanism in vitro. Am J kidney Dis 37:820–831

    Article  CAS  PubMed  Google Scholar 

  • Gao Y, Lu J, Zhang Y, Chen Y, Gu Z, Jiang X (2013) Baicalein attenuates bleomycin-induced pulmonary fibrosis in rats through inhibition of miR-21. Pulm Pharmacol Ther 26:649–654. doi:10.1016/j.pupt.2013.03.006

    Article  CAS  PubMed  Google Scholar 

  • Hou YC, Lin SP, Tsai SY, Ko MH, Chang YC, Chao PD (2011) Flavonoid pharmacokinetics and tissue distribution after repeated dosing of the roots of Scutellaria baicalensis in rats. Planta Med 77:455–460. doi:10.1055/s-0030-1250433

    Article  CAS  PubMed  Google Scholar 

  • Inoue T, Jackson EK (1999) Strong antiproliferative effects of baicalein in cultured rat hepatic stellate cells. Eur J Pharmacol 378:129–135

    Article  CAS  PubMed  Google Scholar 

  • Jones LK et al (2009) IL-1RI deficiency ameliorates early experimental renal interstitial fibrosis. Nephrol Dial Transplant 24:3024–3032. doi:10.1093/ndt/gfp214

    Article  CAS  PubMed  Google Scholar 

  • Klahr S, Morrissey J (2002) Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 283:F861–F875. doi:10.1152/ajprenal.00362.2001

    Article  PubMed  Google Scholar 

  • Kong EK, Yu S, Sanderson JE, Chen KB, Huang Y, Yu CM (2011) A novel anti-fibrotic agent, baicalein, for the treatment of myocardial fibrosis in spontaneously hypertensive rats. Eur J Pharmacol 658:175–181. doi:10.1016/j.ejphar.2011.02.033

    Article  CAS  PubMed  Google Scholar 

  • Lee SB, Kalluri R (2010) Mechanistic connection between inflammation and fibrosis. Kidney Int Suppl 78:S22–S26. doi:10.1038/ki.2010.418

    Article  Google Scholar 

  • Liu Y (2011) Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 7:684–696. doi:10.1038/nrneph.2011.149

    Article  CAS  PubMed  Google Scholar 

  • Liu A et al (2014) Baicalein protects against polymicrobial sepsis-induced liver injury via inhibition of inflammation and apoptosis in mice. Eur J Pharmacol 748C:45–53. doi:10.1016/j.ejphar.2014.12.014

    Google Scholar 

  • Ni H, Chen J, Pan M, Zhang M, Zhang J, Chen P, Liu B (2013) FTY720 prevents progression of renal fibrosis by inhibiting renal microvasculature endothelial dysfunction in a rat model of chronic kidney disease. J Mol Histol 44:693–703. doi:10.1007/s10735-013-9521-8

    Article  CAS  PubMed  Google Scholar 

  • Nightingale J, Oncostatin M et al (2004) A cytokine released by activated mononuclear cells, induces epithelial cell-myofibroblast transdifferentiation via Jak/Stat pathway activation. JASN 15:21–32

    Article  CAS  PubMed  Google Scholar 

  • Oh KS, Oh BK, Park CH, Mun J, Won SH, Lee BH (2012) Baicalein potently inhibits Rho kinase activity and suppresses actin stress fiber formation in angiotensin II-stimulated H9c2 cells. Biol Pharm Bull 35:1281–1286

    Article  CAS  PubMed  Google Scholar 

  • Panzer U et al (2009) Resolution of renal inflammation: a new role for NF-kappaB1 (p50) in inflammatory kidney diseases American journal of physiology. Renal Physiol 297:F429–F439. doi:10.1152/ajprenal.90435.2008

    Article  CAS  Google Scholar 

  • Ricardo SD, van Goor H, Eddy AA (2008) Macrophage diversity in renal injury and repair. J Clin Investig 118:3522–3530. doi:10.1172/JCI36150

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Rodriguez-Pena AB, Grande MT, Eleno N, Arevalo M, Guerrero C, Santos E, Lopez-Novoa JM (2008) Activation of Erk1/2 and Akt following unilateral ureteral obstruction. Kidney Int 74:196–209. doi:10.1038/ki.2008.160

    Article  CAS  PubMed  Google Scholar 

  • Schreiner GF, Harris KP, Purkerson ML, Klahr S (1988) Immunological aspects of acute ureteral obstruction: immune cell infiltrate in the kidney. Kidney Int 34:487–493

    Article  CAS  PubMed  Google Scholar 

  • Shimizu I (2000) Sho-saiko-to: Japanese herbal medicine for protection against hepatic fibrosis and carcinoma. J Gastroenterol Hepatol 15(Suppl):D84–D90

    Article  PubMed  Google Scholar 

  • Shimizu I (2001) Antifibrogenic therapies in chronic HCV infection. Curr Drug Targets Infect Disord 1:227–240

    Article  CAS  PubMed  Google Scholar 

  • Stambe C, Atkins RC, Tesch GH, Masaki T, Schreiner GF, Nikolic-Paterson DJ (2004) The role of p38alpha mitogen-activated protein kinase activation in renal fibrosis. JASN 15:370–379

    Article  CAS  PubMed  Google Scholar 

  • Sun H, Che QM, Zhao X, Pu XP (2010) Antifibrotic effects of chronic baicalein administration in a CCl4 liver fibrosis model in rats. Eur J Pharmacol 631:53–60. doi:10.1016/j.ejphar.2010.01.002

    Article  CAS  PubMed  Google Scholar 

  • Tashiro K et al (2003) Attenuation of renal fibrosis by proteasome inhibition in rat obstructive nephropathy: possible role of nuclear factor kappaB. Int J Mol Med 12:587–592

    CAS  PubMed  Google Scholar 

  • Vielhauer V, Kulkarni O, Reichel CA, Anders HJ (2010) Targeting the recruitment of monocytes and macrophages in renal disease. Semin Nephrol 30:318–333. doi:10.1016/j.semnephrol.2010.03.006

    Article  CAS  PubMed  Google Scholar 

  • Wang YGM, Sun S, Dai J, Cao H, Zheng N, Fang J, Gou X, Lu X, Zhang Y (2012) The effects of baicalein on rat renal fibrosis and the experssions of TGF-β1 and Smad-2 (in Chinese). J Chang Univ Tradit Chin Med 28:383–385

    CAS  Google Scholar 

  • Wu Y, Deng J, Rychahou PG, Qiu S, Evers BM, Zhou BP (2009) Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell 15:416–428. doi:10.1016/j.ccr.2009.03.016

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Wu K, Li H, Tian J, Lei W (2014) Protective effect of baicalein on renal ischemia/reperfusion injury in the rat. Renal Fail 1–7. doi:10.3109/0886022X.2014.991999

  • Zhang X et al (2014) Baicalein ameliorates inflammatory-related apoptotic and catabolic phenotypes in human chondrocytes. Int Immunopharmacol 21:301–308. doi:10.1016/j.intimp.2014.05.006

    Article  CAS  PubMed  Google Scholar 

  • Zheng X et al. (2013) Protective effects of chronic resveratrol treatment on vascular inflammatory injury in streptozotocin-induced type 2 diabetic rats: role of NF-kappa B signaling. Eur J Pharmacol. doi:10.1016/j.ejphar.2013.10.034

Download references

Author information

Author notes

    Authors and Affiliations

    1. Department of Urology, Renmin Hospital of Wuhan University, 99 Ziyang Road, Wuhan, 430060, Hubei Province, China

      Wei Wang, Chang-geng Xu, Xiang-jun Zhou, Wei Hu & Jie Zhang

    2. Department of Orthopedics, Renmin Hospital of Wuhan University, 99 Ziyang Road, Wuhan, 430060, Hubei Province, China

      Pang-hu Zhou

    3. Huangshi Central Hospital, Hubei Polytechnic University, 141 Tianjin Road, Huangshi, 435000, Hubei Province, China

      Jie Zhang

    Authors
    1. Wei Wang
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Pang-hu Zhou
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Chang-geng Xu
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Xiang-jun Zhou
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Wei Hu
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Jie Zhang
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Jie Zhang.

    Additional information

    Wei Wang and Pang-hu Zhou have contributed equally to this article.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Wang, W., Zhou, Ph., Xu, Cg. et al. Baicalein attenuates renal fibrosis by inhibiting inflammation via down-regulating NF-κB and MAPK signal pathways. J Mol Hist 46, 283–290 (2015). https://doi.org/10.1007/s10735-015-9621-8

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s10735-015-9621-8

    Keywords

    Search

    Navigation